Featured Research

from universities, journals, and other organizations

Educating Physicians About Ventilation-perfusion Scanning Leads To Reduced Radiation Exposure

Date:
April 23, 2009
Source:
American Roentgen Ray Society
Summary:
Educating physicians about ventilation-perfusion scanning as an alternative to CT for the diagnosis of pulmonary embolisms led to a 23 percent decrease in patient exposure, according to a study performed at Albert Einstein College of Medicine, Montefiore Medical Center in Bronx, NY.

Educating physicians about ventilation-perfusion scanning (VQ) as an alternative to CT for the diagnosis of pulmonary embolisms led to a 23% decrease in patient exposure, according to a study performed at Albert Einstein College of Medicine, Montefiore Medical Center in Bronx, NY.

“VQ scanning is a nuclear test which shows blood flow to the lung and airflow. When there is a pulmonary embolism, the air can enter normally, but the blood flow will be disrupted, resulting in an abnormal scan,” said Linda Haramati, MD, lead author of the study.

“We are very conscious of radiation exposure in our population,” said Dr. Haramati. Collaborative and educational seminars were held between radiology, nuclear medicine and emergency medicine departments regarding the radiation dose and comparable sensitivities of VQ and CT pulmonary angiography for pulmonary emboli. “The proportion of CT to VQ changed dramatically after our seminars. In 2006 about 60% of the studies were CT, while in 2007, about 60% were VQ. When we looked at radiation exposure, the mean effective dose was reduced by 23%, from 11.5 mSv in 2006 to 8.9 mSv in 2007,” she said.

“CT confers a much higher radiation exposure than VQ scans. However VQ scans are harder to interpret in patients with abnormal chest x-rays, so we, along with our emergency department physicians have decided to perform VQ scans as the preferred imaging modality in patients with normal chest x-rays who were suspected of having pulmonary embolism—in order to decrease radiation exposure,” said Dr. Haramati.

This study will be presented at the 2009 ARRS Annual Meeting in Boston, MA, on Thursday, April 30.


Story Source:

The above story is based on materials provided by American Roentgen Ray Society. Note: Materials may be edited for content and length.


Cite This Page:

American Roentgen Ray Society. "Educating Physicians About Ventilation-perfusion Scanning Leads To Reduced Radiation Exposure." ScienceDaily. ScienceDaily, 23 April 2009. <www.sciencedaily.com/releases/2009/04/090423132957.htm>.
American Roentgen Ray Society. (2009, April 23). Educating Physicians About Ventilation-perfusion Scanning Leads To Reduced Radiation Exposure. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2009/04/090423132957.htm
American Roentgen Ray Society. "Educating Physicians About Ventilation-perfusion Scanning Leads To Reduced Radiation Exposure." ScienceDaily. www.sciencedaily.com/releases/2009/04/090423132957.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins